LHON mutations in Italian patients affected by multiple sclerosis

Acta Neurologica Scandinavica

Volumn 96, Issue 3, 1997, Pages 145-148

  Leuzzi, V ^a,b   Carducci, Ca ^a   Lanza, M ^a   Salvetti, M ^a   Ristori, G ^a   Di Giovanni, S ^a   Torroni, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Istituto Neuropsichiatria Infantile   (Italy)

Author keywords

LHON; MS; mtDNA mutations

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEREDITARY OPTIC ATROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; VISUAL IMPAIRMENT;

EID: 0030774591     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00257.x     Document Type: Article

References (26)

1. WALLACE DC, LOTT MT, BROWN MD, HUOPONEN K, TORRONI A. Mitochondrial DNA Committee Report. In: CUTHICCHIA A, PEARSON PL. eds. Human Gene Mapping, 1994: A Compendium. Baltimore: The Johns Hopkins University Press, 1995: 910-54.
2. HARDING AE, SWEENEY MG, MILLER DH et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992: 115: 979-89.
3. SADOVNICK AD, BULMAN D, EBERS GC. Parent-child concordance in multiple sclerosis. Ann Neurol 1991: 29: 252-5.
4. BROWN MD, WALLACE DC. Spectrum of mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Clin Neurosci 1994: 2: 138-45.
5. OOSTRA R-J, BOLHUIS PA, ZORN-ENDE I et al. Leber's hereditary optic neuropathy: no significant evidence for primary or secondary pathogenicity of the 15257 mutation. Hum Genet 1994: 94: 265-70.
6. MACKEY DA, OOSTRA R-J, ROSENBERG T et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996: 59: 481-6.
7. SAMBROCK J, FRITSCH EF, MANIATIS T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
8. CARDUCCI C, LEUZZI V, SCUDERI et al. Mitochondrial DNA mutation in an Italian family with Leber hereditary optic neuropathy. Hum Genet 1991: 87: 725-8.
9. GERBITZ KD, PAPROTTA A, OBERMAIER-KUSSER B. RIETSCHEL M, ZERRES K. No genetic differences between affected and unaffected members of a German family with Leber's hereditary optic neuropathy (LHON) with respect to ten mtDNA mutations associated with LHON. FEBS 1992: 3: 251-5.
10. NEWMAN N, TORRONI A, BROWN MD, LOTT MT, MARQUEZ FERNANDEZ M, WALLACE DC. Epidemic neuropathy in Cuba not associated with mitochondrial DNA mutations found in Leber's hereditary optic neuropathy patients. Am J Ophthalmol 1994: 118: 158-68.
11. FLANIGAN KM, JOHNS DR. Association of the 11778 mitochondrial DNA mutation and demyelinating disease. Neurology 1993: 43: 2720-2.
12. KELLAR-WOOD H, ROBERTSON N, GOVAN GG, COMPSTON DAS, HARDING AE. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994: 36: 109-12.
13. RIORDAN-EVA P, SANDERS MD, GOVAN GG, SEENEY MG, DA COSTA J, HARDING AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995: 118: 319-37.
14. CARRARA F, EOLI M, LA MANTIA L, ZEVIANI M. The contribution of LHON mitochondrial mutations to multiple sclerosis. Am J Hum Gen 1995: 57: A336.
15. VERGANI L, MARTINUZZI A, CARELLI V et al. MtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. Biochem Biophys Res Commun 1995: 210: 880-8.
16. OLSEN NK, HANSEN AW, NORBY S, EDAL AL, JORGENSEN JR, ROSENBERG T. Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation. Acta Neurol Scand 1995: 91: 326-9.
17. NIKOSKELAINEN EK, MARTTILA RJ, HUOPONEN K et al. Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995: 59: 160-4.
18. JANSEN PHP, VAN DER KNAAP MS, DE COO IFM. Leber's hereditary optic neuropathy with 11778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical. MRI and MRS findings. J Neurol Sci 1996: 135: 176-80.
19. KALMAN B, BROWN MD, LUBLIN FD, ALDER H. Characterization of the mitochondrial DNA in patients with multiple sclerosis. J Neurol Sci 1996: 140: 75-89.
20. CHALMERS RM, ROBERTSON N, COMPSTON DAS, HARDING AE. Sequence of mitochondrial DNA in patients with multiple sclerosis. Ann Neurol 1996: 40: 239-43.
21. NEWMAN NJ, LOTT MT, WALLACE DC. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy. Am J Ophthalmol 1991: 111: 750-62.
22. BAUER HJ. Problems of symptomatic therapy in multiple sclerosis. Neurology 1978: 28: 8-20.
23. KELLY R. Clinical aspects of multiple sclerosis. In KOETSIER JC, ed. Handbook of Clinical Neurology, vol. 3(47): Demyelinating Diseases. Amsterdam: Elsevier Science Publishers, 1985: 49-78.
24. KURTZKE JF. Clinical manifestations of multiple sclerosis. In VINKEN PJ, BRUYN GW, eds. Handbook of Clinical Neurology, vol. 9: Multiple Sclerosis and Other Demyelinating Diseases, Amsterdam: North-Holland Publishing Company, 1970: 161-216.
25. BROWN MD, VOLJAVEC AS, LOTT MT, TORRONI A, YANG C-C, WALLACE DC. Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics 1992: 130: 163-73.
26. TORRONI A, PETROZZI M, D'URBANO L et al. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet (1997, in press).